← All organizations

Horizon Pharma

For profit

Also known as: Horizon | HORIZON | HORIZON PHARMA | Horizon Pharma Ireland, Ltd., Dublin Ireland | Horizon Pharma plc | Horizon Pharma Rheumatology LLC | HORIZON PHARMA USA | Horizon Pharma USA, Inc. | HZNP

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Nov 4, 2022

Acquired by Amgen

Timeline

2000s

Jan 1, 2005
Horizon Pharma— Founded

2010s

Apr 1, 2010
Nitec Pharma AG— Acquired
Apr 30, 2010
naproxen— Marketing Organization
Apr 30, 2010
naproxen— NDA Secondary Org
Jan 1, 2014
Vidara Therapeutics— Acquired
Jan 1, 2015
Crealta— Acquired
Jan 1, 2015
Hyperion Therapeutics— Acquired
Sep 12, 2016
Raptor Pharmaceuticals Corp.— Acquired
May 8, 2017
River Vision Development Corporation— Acquired

Drugs by trial phase (26 distinct, 64 trials)

Phase 4 (5 own, 2 via acquisition)

Phase 3 (3 own, 5 via acquisition)

Phase 2 (4 own, 4 via acquisition)

Phase 1 (2 own, 1 via acquisition)

Marketed drugs (9)

Subsidiaries (6 direct, 11 total across the full acquisition tree)

Recent trials (50)

NCT04040894Lead sponsorN/A—
NCT05626751Lead sponsorPhase 2Nov 4, 2022
NCT04628338CollaboratorEarly Phase 1Nov 30, 2020
NCT04087720Lead sponsorPhase 4Sep 9, 2019
NCT04087720Study directorPhase 4Sep 9, 2019
NCT03994731Study directorPhase 4Jun 13, 2019
NCT03994731Lead sponsorPhase 4Jun 13, 2019
NCT03635957Lead sponsorPhase 2Sep 26, 2018
NCT03635957Study directorPhase 2Sep 26, 2018
NCT03461211Lead sponsorPhase 3Apr 16, 2018
NCT03298867Lead sponsorPhase 3Oct 24, 2017
NCT03112590CollaboratorPhase 1/Phase 2Apr 28, 2017
NCT02797080Study directorPhase 3Jun 1, 2016
NCT02797080Lead sponsorPhase 3Jun 1, 2016
NCT02666768CollaboratorPhase 2Feb 1, 2016

Details

Founded: Northbrook, IL, US Jan 1, 2005
Last known activity: Nov 4, 2022